![Brentuximab vedotin (SGN-35) in Hodgkin lymphoma patients with relapsed after autologous peripheral blood stem-cell transplantation]()
Brentuximab vedotin (SGN-35) in Hodgkin lymphoma patients with relapsed after autologous peripheral blood stem-cell transplantationErdem, G.; Karadurmus, N.; Ozaydin, S.; Karacalioglu, A.O.; Yeginer, C.; Ozturk, M.; Ataergin, S.; Nevruz, O.; Cetin, T.; Arpaci, F. · European Journal of Internal Medicine · 2013